Ouvrages publiés à titre de seul auteur (1)
  1. 1. Van Marion, I. (2018). Enthusiastic connectors: Existing and desired professional profiles of practitioners of patient organizations as knowledge brokers within research projects with patient participation.
    2.   Articles dans des revues avec comité de lecture (6)
  2. 1. Lagendijk, A., Hillebrand, B., Kalmar, E., Van Marion, I., & Sanden, M. V. D. (2019). Blockchain innovation and framing in the Netherlands: How a technological object turns into a ‘hyperobject'. Technology in society, 59, 101175. doi:10.1016/j.techsoc.2019.101175
  3. 2. Horvath, L., Van Marion, I., Taï, K., Nielsen, T. T., & Lundberg, C. (2011). Knockdown of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease. The journal of gene medicine, 13(3), 188-197. doi:10.1002/jgm.1555
  4. 3. Nielsen, T. T., Van Marion, I., Hasholt, L., & Lundberg, C. (2009). Neuron-specific RNA interference using lentiviral vectors. The journal of gene medicine, 11(7), 559-569. doi:10.1002/jgm.1333
  5. 4. Lambrechts, D., Poesen, K., Fernández-Santiago, R., Al-Chalabi, A., Del Bo, R., Van Vught, P. W. J., Khan, S., Marklund, S. L., Brockington, A., Van Marion, I., Anneser, J., Shaw, C., Ludolph, A. C., Leigh, N. P., Comi, G. P., Gasser, T., Shaw, P. J., Morrison, K. E., Andersen, P. M., Van den Berg, L. H., Thijs, V., Siddique, T., Robberecht, W., & Carmeliet, P. (2009). Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. Journal of medical genetics, 46(12), 840-846. doi:10.1136/jmg.2008.058222
  6. 5. Gussing, F., Van Marion, I., Ralets, I., & Lundberg, C. (2009). Selective protein expression within the CNS using hybrid lentivirus. Methods in molecular biology, 515, 215-226. doi:10.1007/978-1-59745-559-6_14
  7. 6. Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., Van Marion, I., Al-Chalabi, A., Bornes, S., Musson, R., Hansen, V., Beckman, L., Adolfsson, R., Pall, H. S., Prats, H., Vermeire, S., Rutgeerts, P., Katayama, S., Awata, T., Leigh, N., Lang-Lazdunski, L., Dewerchin, M., Shaw, C. E., Moons, L., Vlietinck, R., Morrison, K. E., Robberecht, W., Van Broeckhoven, C., Collen, D., Andersen, P. M., & Carmeliet, P. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nature genetics, 34(4), 383-394. doi:10.1038/ng1211
    8.   Participations à des congrès et colloques internationaux (7)
  8. 1. Domingo, D., Van Marion, I., & de Valeriola, S. (2025). Dictatorship of scientists? Tensions around scientific advice during the COVID-19 crisis. Paper session presented at Public Communication of Science and Technology (PCST) Conference (26-30/5/2025: Aberdeen).
  9. 2. Van Marion, I., & Domingo, D. (2025). Science communication in evidence-informed policy-making: Building an integrative theoretical framework to understand barriers and facilitators. Paper session presented at Eetmal van de Communicatiewetenschap (NeFCA) (3-4/2/2025: Brugge).
  10. 3. Van Marion, I., & Domingo, D. (2025). Epistemic trespassing as a hurdle for EIPM: Implications for the ethics of science communication. Paper session presented at Philisophy of Science Advice Workshop (12-13/6/2025: Helsinki).
  11. 4. Van Marion, I., & Domingo, D. (2025). Creating Connections: Evidence-Based Science Communication for Evidence-Informed Policy-Making. Paper session presented at Public Communication of Science and Technology (PCST) Conference (26-30/6/2025: Aberdeen).
  12. 5. Van Marion, I., & Domingo, D. (2025). A study on the communication of science for policy. Paper session presented at Symposium: Effectieve communicatie voor pandemische paraatheid (Amsterdam Center for Health Communication) (8/4/2025: Amsterdam).
    13. << Précédent 1 2 Suivant >>